Doctor profile · Federal record
Dr. Rhonda Gabr, M.D.
Neurology Physician (CMS: Neurology) · Raleigh, NC
- NPI 1609803949
- Accepts Medicare
- MIPS 87.2 / 100 · 2023
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1540 Sunday Dr
Raleigh, NC 276076000
(919) 782-3456
fax (919) 787-7552
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- April 1, 2021
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- North Carolina #200101046
- Medicaid
- NC #89132AU
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609803949. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
53,186
Distinct HCPCS
10
Medicare allowed
$949,169
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0585 |
Injection, onabotulinumtoxina, 1 unit | 31,200 | 47 | $6 | |
J2323 |
Injection, natalizumab, 1 mg | 9,900 | 19 | $24 | |
J2350 |
Injection, ocrelizumab, 1 mg | 6,300 | 11 | $54 | |
A9585 |
Injection, gadobutrol, 0.1 ml | 3,150 | 29 | $0 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,740 | 12 | $48 | |
64615 |
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 157 | 48 | $142 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 99 | 20 | $5 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 93 | 39 | $53 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 78 | 46 | $82 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 64 | 48 | $172 |
In context: peer comparison
Among 17 peers in Raleigh Neurology Physician, average services per provider: 1,155. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$665
Transactions
26
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | 2 | $200.00 | |
| Novartis Pharmaceuticals Corporation | 4 | $84.07 | |
| Argenx US, INC. | 3 | $54.48 | |
| Abbvie INC. | 2 | $43.53 | |
| Neurelis, INC. | 2 | $37.59 | |
| Aucta Pharmaceuticals, INC. | 3 | $35.63 | |
| Neurocrine Biosciences, INC. | 2 | $32.33 | |
| Lundbeck LLC | 1 | $30.90 | |
| Tg Therapeutics, INC. | 1 | $30.85 | |
| Eisai INC. | 1 | $27.28 | |
| Biogen, INC. | 1 | $20.48 | |
| Pfizer INC. | 1 | $19.54 | |
| Ucb, INC. | 1 | $19.29 | |
| Lilly USA, LLC | 1 | $14.92 | |
| Amneal Pharmaceuticals LLC | 1 | $13.88 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
771
Patients
164
Total drug cost
$130,821
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 105 | 35 | $3,004 |
| Donepezil Hcl | Generic | 87 | 27 | $1,711 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 60 | 16 | $2,608 |
| Memantine Hcl | Generic | 56 | 15 | $1,588 |
| Diazepam | Generic | 51 | 11 | $285 |
| Tizanidine Hcl | Generic | 51 | 12 | $649 |
| Nortriptyline Hcl | Generic | 46 | 11 | $818 |
| Nurtec Odt (Rimegepant Sulfate) | Brand | 45 | 12 | $49,923 |
| Rizatriptan (Rizatriptan Benzoate) | Brand | 45 | 0 | $972 |
| Emgality Pen (Galcanezumab-Gnlm) | Brand | 41 | 0 | $34,667 |
Hospital affiliations
Frequently asked questions
What is Dr. Rhonda Gabr's medical specialty?
Dr. Rhonda Gabr practices Neurology Physician in Raleigh, NC.
Where does Dr. Rhonda Gabr practice?
Dr. Rhonda Gabr practices at 1540 Sunday Dr, Raleigh, NC 276076000. Office phone: 9197823456.
What is Dr. Rhonda Gabr's NPI?
Dr. Rhonda Gabr's National Provider Identifier (NPI) is 1609803949, issued by NPPES.
Does Dr. Rhonda Gabr accept Medicare assignment?
Yes. Dr. Rhonda Gabr accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rhonda Gabr commonly perform?
Top Medicare-reported procedures in 2023: Injection, onabotulinumtoxina, 1 unit (HCPCS J0585); Injection, natalizumab, 1 mg (HCPCS J2323); Injection, ocrelizumab, 1 mg (HCPCS J2350). Source: CMS Medicare Physician & Other Practitioners file.